These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9303070

  • 1. Multistage carcinogenesis modeling and the initiation event.
    Chadwick KH, Leenhouts HP.
    Radiat Oncol Investig; 1997; 5(3):129-33. PubMed ID: 9303070
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M.
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [Abstract] [Full Text] [Related]

  • 3. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll.
    Little MP.
    Biometrics; 1995 Dec; 51(4):1278-91. PubMed ID: 8589222
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M, Luebeck EG, Moolgavkar SH.
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [Abstract] [Full Text] [Related]

  • 5. Using a biologically motivated cancer model to understand dose and temporal radiation effects.
    Leenhouts HP, Brugmans MJ.
    Radiat Res; 2000 Dec; 154(6):729-30;discussion 730-1. PubMed ID: 11187017
    [No Abstract] [Full Text] [Related]

  • 6. Distinguishing between models of carcinogenesis: the role of clonal expansion.
    Kopp-Schneider A, Portier CJ.
    Fundam Appl Toxicol; 1991 Oct; 17(3):601-13. PubMed ID: 1794662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of promotion in carcinogenesis from protracted high-LET exposure.
    Curtis SB, Luebeck EG, Hazelton WD, Moolgavkar SH.
    Phys Med; 2001 Oct; 17 Suppl 1():157-60. PubMed ID: 11771544
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interpretation by modelling of observations in radon radiation carcinogenesis.
    Heidenreich WF, Paretzke HG.
    Radiat Prot Dosimetry; 2004 Oct; 112(4):501-7. PubMed ID: 15623885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Testing extrapolation of a biologically based exposure-response model from in vitro to in vivo conditions.
    Mebust M, Crawford-Brown D, Hofmann W, Schöllnberger H.
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):72-9. PubMed ID: 11846637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
    Harrison JD, Muirhead CR.
    Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data.
    Izumi S, Ohtaki M.
    Biom J; 2007 Aug; 49(4):539-50. PubMed ID: 17722193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.